Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

β-Acetyl-γ-O-alkyl-L-α-phosphatidylcholine (CAS 65154-06-5)

0.0(0)
Write a reviewAsk a question

Alternate Names:
2-(acetyloxy)-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate
Application:
β-Acetyl-γ-O-alkyl-L-α-phosphatidylcholine is a phospholipid which induces platelet aggregation
CAS Number:
65154-06-5
Molecular Weight:
523.68
Molecular Formula:
C26H54NO7P
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

β-Acetyl-γ-O-alkyl-L-α-phosphatidylcholine is a synthetically modified phospholipid notable for its unique structural alterations, including acetylation at the beta position and alkylation at the gamma position on the glycerol backbone. These modifications confer distinct physicochemical properties that are leveraged in biophysical research to explore membrane dynamics and architecture. This chemical is particularly valuable for constructing and studying model lipid membranes, offering insights into how such structural alterations affect lipid bilayer behavior, including phase transitions, fluidity, and stability. Researchers utilize β-Acetyl-γ-O-alkyl-L-α-phosphatidylcholine to simulate the complexities of natural lipid membranes, facilitating studies on membrane curvature, domain formation, and the organization of lipids around integral membrane proteins. By manipulating the lipid composition in these model systems, scientists can observe the effects on membrane properties such as thickness, permeability, and mechanical strength, which are crucial for understanding fundamental cellular processes related to membrane structure and function. This synthetic lipid thus serves as an essential tool in membrane biophysics, helping to explain the roles of specific lipid modifications in the broader context of lipid-mediated cellular phenomena without the interference of biological variability.


β-Acetyl-γ-O-alkyl-L-α-phosphatidylcholine (CAS 65154-06-5) References

  1. Phospholipid identification and quantification of membrane vesicle subfractions by 31P-1H two-dimensional nuclear magnetic resonance.  |  Larijani, B., et al. 2000. Lipids. 35: 1289-97. PMID: 11132188
  2. Mechanisms underlying endothelium-dependent, nitric oxide- and prostanoid-independent relaxation in monkey and dog coronary arteries.  |  Fujioka, H., et al. 2002. Naunyn Schmiedebergs Arch Pharmacol. 366: 488-95. PMID: 12382080
  3. Platelet-activating factor: a previously unrecognized mediator of fever.  |  Ivanov, AI., et al. 2003. J Physiol. 553: 221-8. PMID: 14565987
  4. Conformational activation of CD11b without shedding of L-selectin on circulating human neutrophils.  |  Orr, Y., et al. 2007. J Leukoc Biol. 82: 1115-25. PMID: 17675559
  5. Platelet-activating factor changes in phospholipid extracts from the plasma, peripheral blood mononuclear cells and bone marrow mononuclear cells of patients with acute leukemia--a 31P MRS in vitro study.  |  Kuliszkiewicz-Janus, M., et al. 2008. Cell Mol Biol Lett. 13: 58-66. PMID: 17952375
  6. The platelet activating factor triggers preconditioning-like cardioprotective effect via mitochondrial K-ATP channels and redox-sensible signaling.  |  Penna, C., et al. 2008. J Physiol Pharmacol. 59: 47-54. PMID: 18441387
  7. Platelet-activating factor in Iberian pig spermatozoa: receptor expression and role as enhancer of the calcium-induced acrosome reaction.  |  Bragado, MJ., et al. 2011. Reprod Domest Anim. 46: 943-9. PMID: 22023717
  8. Platelet-activating factor is a potent pyrogen and cryogen, but it does not mediate lipopolysaccharide fever or hypothermia.  |  Steiner, AA. and Romanovsky, AA. 2015. Temperature (Austin). 2: 535-42. PMID: 27227073
  9. The pathophysiological effects of Russell's viper (Daboia siamensis) venom and its fractions in the isolated perfused rabbit kidney model: A potential role for platelet activating factor.  |  Chaiyabutr, N., et al. 2020. Toxicon X. 7: 100046. PMID: 32875291
  10. Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer.  |  Souza, JL., et al. 2020. Front Oncol. 10: 557280. PMID: 33392068

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

β-Acetyl-γ-O-alkyl-L-α-phosphatidylcholine, 1 mg

sc-214466
1 mg
$98.00

β-Acetyl-γ-O-alkyl-L-α-phosphatidylcholine, 5 mg

sc-214466A
5 mg
$510.00